Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript - PubMed (original) (raw)

Affiliations

PMID: 8208549

Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript

A Moghul et al. Oncogene. 1994 Jul.

Abstract

The c-MET proto-oncogene product is a transmembrane tyrosine kinase receptor which was recently shown to transmit an array of important cellular responses induced by Hepatocyte Growth Factor (HGF). These biological effects include induction of mitogenesis, motogenesis, morphogenesis, metastogenesis and anti-tumor activity on a variety of epithelial cells. All of these processes are known to be associated with normal and abnormal tissue growth and development. The 190 kDa c-MET protein is encoded by a major transcript of 8 kilobases (kb), which is reported to be expressed predominantly in epithelial tissues. The expression pattern of c-MET mRNA and protein are drastically modified in many tumor tissues and cell lines. Currently, no information is available on the molecular mechanisms that regulate c-MET mRNA level. In the present communication, we report for the first time that the inflammatory cytokines such as IL-1 alpha, IL-6 and TNF-alpha, as well as TGF-beta 1, EGF, HGF and the steroidal hormones (estrogen, progesterone, tamoxifen and dexamethasone) markedly influence the steady-state levels of the 8 kb c-MET mRNA in human carcinoma cell lines derived from human tissues such as ovary, breast and endometrium. We demonstrate that c-MET receptor protein is present at high levels in primary tumors of human ovaries (clear cell carcinomas). We present evidence that the 8 kb c-MET mRNA undergoes rapid degradation with a half-life of less than 30 min and that this decay can be quickly inhibited by cycloheximide. Our results suggest that the expression of the c-met proto-oncogene resembles that of an immediate early response gene.

PubMed Disclaimer

Cited by

TNF-α promotes invasive growth through the MET signaling pathway.
Bigatto V, De Bacco F, Casanova E, Reato G, Lanzetti L, Isella C, Sarotto I, Comoglio PM, Boccaccio C. Bigatto V, et al. Mol Oncol. 2015 Feb;9(2):377-88. doi: 10.1016/j.molonc.2014.09.002. Epub 2014 Sep 26. Mol Oncol. 2015. PMID: 25306394 Free PMC article.
Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.
Huntsman D, Resau JH, Klineberg E, Auersperg N. Huntsman D, et al. Am J Pathol. 1999 Aug;155(2):343-8. doi: 10.1016/S0002-9440(10)65130-9. Am J Pathol. 1999. PMID: 10433927 Free PMC article.
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.
Zarnegar R, Michalopoulos GK. Zarnegar R, et al. J Cell Biol. 1995 Jun;129(5):1177-80. doi: 10.1083/jcb.129.5.1177. J Cell Biol. 1995. PMID: 7775566 Free PMC article. Review. No abstract available.
Autocrine secretion of TGF-beta 1 and TGF-beta 2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells.
Rahimi N, Tremblay E, McAdam L, Roberts A, Elliott B. Rahimi N, et al. In Vitro Cell Dev Biol Anim. 1998 May;34(5):412-20. doi: 10.1007/s11626-998-0023-z. In Vitro Cell Dev Biol Anim. 1998. PMID: 9639104
Targeting MET transcription as a therapeutic strategy in multiple myeloma.
Phillip CJ, Stellrecht CM, Nimmanapalli R, Gandhi V. Phillip CJ, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):587-97. doi: 10.1007/s00280-008-0770-2. Epub 2008 May 29. Cancer Chemother Pharmacol. 2009. PMID: 18509644 Free PMC article.

Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript - PubMed (original) (raw)